Szabo S, Horner HC, Gallagher GT: Drug-induced duodenal ulcer;In Drugs and Peptic Ulcers. CJ Pfeiffer (ed). Boca Raton, Florida, CRC Press, 1981, pp 55–74
Google Scholar
Szabo S, Pihan G, Gallagher GT, Brown: A role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcers. Scand J Gastroenterol 19:106–111, 1984
Google Scholar
Pihan G, Kline TJ, Hollenberg NK, Szabo S: Duodenal ulcerogens cysteamine and propionitrile induce gastroduodenal motility alterations in the rat. Gastroenterology 88:989–997, 1985
PubMed
Google Scholar
Hernadez DE, Adcock JW, Orlando RC, Patric KS, Nemeroff CB, Prange AJ: Prevention of stress-induced gastric ulcers by dopamine agonists in the rat. Life Sci 35:2453–2458, 1984
PubMed
Google Scholar
Hernadez DE, Stanley DA, Melvin JA, Prange AJ: Role of brain neurotransmitters on neurotensin-induced gastric cytoprotection. Pharmacol Biochem Behav 22:509–513, 1985
PubMed
Google Scholar
Kumagai H, Urakawa K, Asaka Y, Ito A, Sano I, Saito Y: Role of dopamine in prevention of stress-induced gastric lesions. Exp Ulcer 14:23, 1986 (abstract)
Google Scholar
Takeuchi K, Nishiwaki H, Okabe S: Role of local motility changes in the pathogenesis of duodenal ulcers induced by cysteamine in rats. Dig Dis Sci 32:295–304, 1987
PubMed
Google Scholar
Mersereau WA, Hinchey EJ: Prevention of phenylbutazone ulcer in the rat by glucose; role of a glycoprivic receptor system. Am J Physiol 242:G429-G432, 1982
PubMed
Google Scholar
Merserau WA, Hinchey EJ: Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 91:150–155, 1982
PubMed
Google Scholar
Garrick T, Buack S, Bass P: Gastric motility is a major factor in cold restraint-induced lesion formation in rats. Am J Physiol 250:G191-G199, 1986
PubMed
Google Scholar
Takeuchi K, Ueki S, Okabe S: Importance of gastric motility in the pathogenesis of indomethacin-induced gastric lesions in rats. Dig Dis Sci 31:1114–1122, 1986
PubMed
Google Scholar
Takeuchi K, Nobuhara Y: Inhibition of gastric motor activity by 16, 16-dimethyl prostaglandin E2; a possible explanation of cytoprotection. Dig Dis Sci 30:1181–1188, 1985
PubMed
Google Scholar
Takeuchi K, Nishiwaki H, Okabe S: Cytoprotective action of mast cell stabilizers against ethanol-induced gastric lesions in rats. Jpn J Pharmacol 42:297–307, 1986
PubMed
Google Scholar
Mizui T, Doteuchi M: Effects of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol 33:939–946, 1983
PubMed
Google Scholar
Whittle BJR, Higgs GA, Eakins KE, Moncada S, Vane JR: Selective inhibition of prostaglandin production in inflammatory exudate and gastric mucosa. Nature 284:271–273, 1980
PubMed
Google Scholar
Yeh BK, McNay JL, Goldberg LI: Attenuation of dopamine on renal and mesenteric vasodilatation by haloperidol; evidence for a specific dopamine receptor. J Pharmacol Exp Ther 168:303–309, 1969
PubMed
Google Scholar
Nylander O, Flemstrom G: Effects of alpha-adrenoceptor agonists and antagonists on duodenal surface epithelial HCO−
3 secretion in the ratin vivo. Acta Physiol Scand 126:433–441, 1986
PubMed
Google Scholar
Merserau WA, Hinchey EJ: Dissolution of mucosal foldings by prostaglandin; an explanation of cytoprotection. Gastroenterology 80:1230, 1981 (abstract)
Google Scholar
Mersereau WA, Hinchey EJ: Role of local factors in duodenal ulcer formation in the cysteamine treated rats; a channel hypothesis.In Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract. A Allen, G Flemstrom, A Garner, W Silen, LA Turnberg (eds). New York, Raven Press, 1984, pp 65–73
Google Scholar
Dunnett CW: A multiple comparison procedure for compairing several treatments with a control. Am J Stat Assoc 50:1096–1121, 1955
Google Scholar
Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ: Mild irritants prevent gastric necrosis through “adaptive cytoprotection” mediated by prostaglandins. Am J Physiol 245:G113-G121, 1983
PubMed
Google Scholar
Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats; prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77:433–443, 1979
PubMed
Google Scholar
Robert A: Cytoprotection: Definition and concept. Gastroenterol Clin Biol 12:7–8, 1985
Google Scholar
Konturek SJ, Brozozowski T, Radecki T: Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion 27:159–163, 1983
PubMed
Google Scholar
Dupuy D, Szabo S: Protection by metals against ethanol-induced gastric mucosal injury in the rat. Comparative biochemical and pharmacological studies implicate protein sulfhydryls. Gastroenterology 91:966–974, 1986
PubMed
Google Scholar
Dharmsathaphorn K, Yamashiro DJ, Lindeborg D, Mandel KG, McRoberts J, Ruffolo PR: Effects of structure-activity relationships of alpha-adrenergic compounds on electrolyte transport in the rabbit ileum and rat colon. Gastroenterology 86:120–128, 1984
PubMed
Google Scholar
Landsberg L, Berardino MB, Silva P: Metabolism3H-l-dopaby the rat gutin vivo; evidence for glucronide conjugation. Biochem Pharmacol 24:1167–1174, 1975
PubMed
Google Scholar
Takeuchi K, Nishiwaki H, Ishihara Y, Okabe S: Roles of gastric motility changes in cytoprotection induced by acetazolamide and cysteamine in rats. Jpn J Pharmacol 44:269–281, 1987
PubMed
Google Scholar
Szabo S, Trier JS, Brown A, Schnoor J: Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 88:228–236, 1985
PubMed
Google Scholar
Pihan G, Majzoubi D, Haudenschild C, Trier JS, Szabo S: Early microcirculatory stasis in acute gastric mucosal injury in the rat and prevention by 16, 16-dimethyl prostaglandin E2 or sodium thiosulfate. Gastroenterology 91:1415–1426, 1986
PubMed
Google Scholar
Mersereau WA, Lough JO, Hinchey EJ: Microvascular injury; secondary to deep corrosion of the crest of the gastric mucosal folds in 0.6 N HCl treated rats. Dig Dis Sci 30:389, 1985 (abstract)
Google Scholar
Innes IR, Nickerson M: Drugs acting on postganglionic adrenergic nerve endings and structures innervated by them (sympathomimetic drugs).In The Pharmacological Basis of Therapeutics. LS Goodman, A Gilman (eds). London, Macmillan, 1970, pp 478–523
Google Scholar